Evidence map›Paper›PMID 41768790›Full record

ArticleBrain communications2026

Plasmalogen deficiency and the Alzheimer's disease risk of apolipoprotein E4.

Jenny Hällqvist, Jan-Willem Taanman, Andreas Göteson, Wendy E Heywood, Jonathan M Schott, John Hardy, Mikael Landén, Henrik Zetterberg, Kevin Mills, Lionel Ginsberg

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Brain communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jenny HällqvistTranslational Mass Spectrometry Research Group, UCL Great Ormond Street Institute of Child Health, London WC1N 1EH, UK.
Jan-Willem TaanmanDepartment of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London NW3 2PF, UK.
Andreas GötesonDepartment of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg 431 41, Sweden.
Wendy E HeywoodTranslational Mass Spectrometry Research Group, UCL Great Ormond Street Institute of Child Health, London WC1N 1EH, UK.ORCID https://orcid.org/0000-0003-2106-8760
Jonathan M SchottDementia Research Centre, UCL Queen Square Institute of Neurology, London WC1N 3BG, UK.ORCID https://orcid.org/0000-0003-2059-024X
John HardyDepartment of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London WC1N 3BG, UK.
Mikael LandénDepartment of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg 431 41, Sweden.
Henrik ZetterbergDepartment of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg 431 41, Sweden.
Kevin MillsTranslational Mass Spectrometry Research Group, UCL Great Ormond Street Institute of Child Health, London WC1N 1EH, UK.
Lionel GinsbergDepartment of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London NW3 2PF, UK.ORCID https://orcid.org/0009-0001-3159-3166

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The ε4 allele of the

Indexed as

Alzheimer’s diseaseapolipoprotein Eethanolamine plasmalogenisoformlipidomics

Identifiers

PMID41768790
PMCPMC12946155

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.